Brian Douglas King - Jan 3, 2022 Form 4 Insider Report for NOVANTA INC (NOVT)

Role
Director
Signature
/s/ John Burke, Attorney-in-Fact
Stock symbol
NOVT
Transactions as of
Jan 3, 2022
Transactions value $
$0
Form type
4
Date filed
1/5/2022, 03:37 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NOVT Common Stock Options Exercise +531 +31.72% 2.21K Jan 4, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NOVT Restricted Stock Units Options Exercise -531 -100% 0 Jan 4, 2022 Common Stock 531 Direct F1
transaction NOVT Restricted Stock Units Award $0 +359 $0.00 359 Jan 3, 2022 Common Stock 359 Direct F2, F3
transaction NOVT Deferred Stock Units Award +359 +7.55% 5.12K Jan 3, 2022 Common Stock 359 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2022, the RSUs were settled in Novanta Inc. common shares.
F2 Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date).
F3 The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date.
F4 As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date.

Remarks:

Power of Attorney on file